is glp-1 a biologic medications get at the heart of addiction: study – WashU Medicine Evolution of GLP‐1 Receptor Agonists
Description
doi:10.1200/JCO.2026.44.16_suppl.3143 Yesho DH, Megiso M, Ugwu C, et al
it's about improving your long-term health and reclaiming your vitality
Overall, tirzepatides dual agonism of GLP1 and GIP receptors appears to provide encouraging cardiovascular benefits beyond glycemic control, offering a potential new therapeutic option for treating cardiovascular diseases and heart failure
Martin-Vias JJ, Quigley EM
Theyre filling a big gap in obesity care
Why tirzepatide costs more: Dual-agonist complexity (GLP-1 + GIP) requires more advanced compounding techniques
